Hypoxia induces BMP-2 expression via ILK, Akt, mTOR, and HIF-1 pathways in osteoblasts

Journal of Cellular Physiology

Volumn 223, Issue 3, 2010, Pages 810-818

  Tseng, Wen Pei ^a   Yang, Shu Ning ^a   Lai, Chih Ho ^b   Tang, Chih Hsin ^b,c  

^a NATIONAL CHANGHUA UNIVERSITY OF EDUCATION   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; HYPOXIA INDUCIBLE FACTOR 1; INTEGRIN LINKED KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; RAPAMYCIN; BMP2 PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTEGRIN-LINKED KINASE; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; HUMAN CELL; HYPOXIA; OSSIFICATION; OSTEOBLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; STROMA CELL; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL HYPOXIA; CELL LINE; ENZYMOLOGY; METABOLISM; MOUSE; PHYSIOLOGY; PROMOTER REGION; SIGNAL TRANSDUCTION;

MAMMALIA;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL HYPOXIA; CELL LINE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; OSTEOBLASTS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 77951242575     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22104     Document Type: Article

References (43)

1. Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P. 2002. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in associationwith an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 22:393-403. (Pubitemid 34273595)
2. Bunn HF, Poyton RO. 1996. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76:839-885. (Pubitemid 26286080)
3. Cordova A, Anghileri L, Saunier C. 1994. Effect of hypoxia and exercise on the distribution of 65Zn in rat muscles. Physiol Behav 55:413-416. (Pubitemid 24088005)
4. Dodd JS, Raleigh JA, Gross TS. 1999. Osteocyte hypoxia: A novel mechanotransduction pathway. Am J Physiol 277:C598-C602.
5. Epari DR, Lienau J, Schell H, Witt F, Duda GN. 2008. Pressure, oxygen tension and temperature in the periosteal callus during bone healing-An in vivo study in sheep. Bone 43:734-739.
6. Fleet JC, Cashman K, Cox K, Rosen V. 1996. The effects of aging on the bone inductive activity of recombinant human bone morphogenetic protein-2. Endocrinology 137:4605-4610. (Pubitemid 26403295)
7. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL. 2002. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277:38205-38211. (Pubitemid 35154674)
8. Hirao M, Hashimoto J, Yamasaki N, Ando W, Tsuboi H, Myoui A, Yoshikawa H. 2007. Oxygen tension is an importantmediator of the transformation of osteoblasts to osteocytes. J Bone Miner Metab 25:266-276.
9. Hochachka PW, Clark CM, Holden JE, Stanley C, Ugurbil K, Menon RS. 1996. 31P magnetic resonance spectroscopy of the Sherpa heart: A phosphocreatine/ adenosine triphosphate signature of metabolic defense against hypobaric hypoxia. Proc Natl Acad Sci USA 93:1215-1220.
10. Hwang JM, Weng YJ, Lin JA, Bau DT, Ko FY, Tsai FJ, Tsai CH, WuCH, Lin PC, Huang CY, Kuo WW. 2008. Hypoxia-induced compensatory effect as related to Shh and HIF-1alpha in ischemia embryo rat heart. Mol Cell Biochem 311:179-187.
11. Jiang BH, Semenza GL, Bauer C, Marti HH. 1996. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. AmJ Physiol 271:C1172-C1180.
12. Jiang BH, Jiang G, Zheng JZ, Lu Z, Hunter T, Vogt PK. 2001. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ 12: 363-369.
13. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L. 1999. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 274:6519-6525.
14. Komatsu DE, Hadjiargyrou M. 2004. Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone 34:680-688.
15. Koumenis C, Naczki C, Koritzinsky M, Rastani S, Diehl A, Sonenberg N, Koromilas A, Wouters BG. 2002. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol Cell Biol 22:7405-7416.
16. Lee SP, Youn SW, Cho HJ, Li L, Kim TY, Yook HS, Chung JW, Hur J, Yoon CH, Park KW, Oh BH, Park YB, Kim HS. 2006. Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue. Circulation 114:150-159.
17. Lu DY, Liou HC, Tang CH, Fu WM. 2006. Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha. Biochem Pharmacol 72:992-1000.
18. Massague J. 1998. TGF-beta signal transduction. Annu Rev Biochem 67:753-791.
19. Matsumoto A, Yamaji K, Kawanami M, Kato H. 2001. Effect of aging on bone formation induced by recombinant human bone morphogenetic protein-2 combined with fibrous collagen membranes at subperiosteal sites. J Periodontal Res 36:175-182.
20. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275.
21. Mojsilovic-Petrovic J, Callaghan D, Cui H, Dean C, Stanimirovic DB, Zhang W. 2007. Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes. J Neuroinflammation 4:12.
22. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S. 2001. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: Critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 276:27462-27469.
23. Rodan GA, Martin TJ. 2000. Therapeutic approaches to bone diseases. Science 289:1508-1514.
24. Salceda S, Caro J. 1997. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272:22642-22647.
25. Salim A, Nacamuli RP, Morgan EF, Giaccia AJ, Longaker MT. 2004. Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. J Biol Chem 279:40007-40016.
26. Schipani E. 2006. Hypoxia and HIF-1alpha in chondrogenesis. Ann NY Acad Sci 1068:66-73.
27. Schneider A, Younis RH, Gutkind JS. 2008. Hypoxia-induced energy stress inhibits themTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma. Neoplasia 10:1295-1302.
28. Semenza GL. 2000. Expression of hypoxia-inducible factor 1:Mechanisms and consequences. Biochem Pharmacol 59:47-53.
29. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A. 1996. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271:32529-32537.
30. Sharp FR, Bernaudin M. 2004. HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5:437-448.
31. Sofer A, Lei K, Johannessen CM, Ellisen LW. 2005. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 25:5834-5845.
32. Su JL, Yang CY, Zhao M, Kuo ML, Yen ML. 2007. Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. J Biol Chem 282:19385-19398.
33. Tan C, Cruet-Hennequart S, Troussard A, Fazli L, Costello P, Sutton K, Wheeler J, Gleave M, Sanghera J, Dedhar S. 2004. Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 5:79-90.
34. Tan TW, Yang WH, Lin YT, Hsu SF, Li TM, Kao ST, Chen WC, Fong YC, Tang CH. 2009. Cyr61 increasesmigration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells. Carcinogenesis 30:258-268.
35. Tang CH, Lu DY, Tan TW, Fu WM, Yang RS. 2007. Ultrasound induces hypoxia-inducible factor-1 activation and inducible nitric-oxide synthase expression through the integrin/integrin-linked kinase/Akt/mammalian target of rapamycin pathway in osteoblasts. J Biol Chem 282:25406-25415.
36. Troussard AA, Mawji NM, Ong C, Mui A, St-Arnaud R, Dedhar S. 2003. Conditional knockout of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem 278:22374-22378.
37. Wang GL, Jiang BH, Rue EA, Semenza GL. 1995. Hypoxia-inducible factor 1 is a basic-helixloop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510-5514.
38. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. 1988. Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534.
39. Wu C, Dedhar S. 2001. Integrin-linked kinase (ILK) and its interactors: A new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 155:505-510.
40. Wu JB, Fong YC, Tsai HY, Chen YF, Tsuzuki M, Tang CH. 2008. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol 588:333-341.
41. Yau CY, Wheeler JJ, Sutton KL, Hedley DW. 2005. Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHRpathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts. Cancer Res 65:1497-1504.
42. Zahm AM, Bucaro MA, Srinivas V, Shapiro IM, Adams CS. 2008. Oxygen tension regulates preosteocyte maturation and mineralization. Bone 43:25-31.
43. Zhao M, Harris SE, Horn D, Geng Z, Nishimura R, Mundy GR, Chen D. 2002. Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J Cell Biol 157:1049-1060.